| Issue |
BIO Web Conf.
Volume 184, 2025
The 3rd International Seminar of the Indonesian Society for Biochemistry and Molecular Biology (ISISBMB 2025)
|
|
|---|---|---|
| Article Number | 02002 | |
| Number of page(s) | 5 | |
| Section | Biochemistry Innovations in Agriculture | |
| DOI | https://doi.org/10.1051/bioconf/202518402002 | |
| Published online | 12 August 2025 | |
The Effect of Ocimum tenuiflorum Ethanolic Extract on Cholesterol Level of Diabetic Mice
1 Faculty of Medicine and Health Science, Universitas Warmadewa, Denpasar 80239, Indonesia
2 Lyceum of the Philipines, University (LPU), Cavite 4107, Philippines
3 Faculty of Agriculture, Universitas Warmadewa, Denpasar 80239, Indonesia
* Corresponding author: nayakasih@warmadewa.ac.id
Dyslipidemia are conditions that frequently occur with Diabetes Melitus. Several previous studies have reported suboptimal management of dyslipidemia. The effect of Ocimum tenuiflorum or holy basil as anti-dyslipidemia has not been widely reported. This study was conducted to evaluate the effect of Ocimum tenuiflorum extract on the colesterol leve lof diabetic mice. In this study, we prepared 18 diabetes mice and divided into 3 groups based on the treatment, as follow: treatment 1 (56 mg/kgBW of Ocimum tenuiflorum extract), treatment 2 (112 mg/kgBW of Ocimum tenuiflorum extract), and control. Cholesterol level was measured after 2 weeks of treatment. The lowest colesterol level after treatment was in Group 2 (112 mg/kgBW), followed by Group 1 (56 mg/kgBW), and the last, or the highest colesterol level was had by control group. The difference in mean of colesterol level after treatment between groups was found to be significant based on the One Way Anova and Post hoc Tamhane tests with a P value <0.05. These findings can support the potential of Ocimum tenuiflorum as a new pharmacotherapeutic agent for the management of diabetes-induced dyslipidemia. Additional research is needed to to evaluate this potency in humans.
© The Authors, published by EDP Sciences, 2025
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.